Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications originally developed for type 2 diabetes management, with select agents now FDA-approved for chronic weight management
Chang G, Liu J, Qin S, Jiang Y, Zhang P, Yu H, Lu K, Zhang N, Cao L, Wang Y
You check in with the team on a set schedule, and those follow-ups let your provider see how you are tolerating the medication and adjust the dose up, hold it, or ease it back
If you are considering stopping the medication, say so
Ethical use of mice for the experiments reported here were also in accordance with an animal use protocol (IACUC #338) that was approved by the Institutional Animal Care and Use Committee of SUNY Upstate Medical University